Src is a major signaling component for CTGF induction by TGF-β1 in osteoblasts

Journal of Cellular Physiology

Volumn 224, Issue 3, 2010, Pages 691-701

  Zhang, X ^a   Arnott, J A ^b   Rehman, S ^a   DeLong Jr , W G ^a   Sanjay, A ^a   Safadi, F F ^a   Popoff, S N ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Janet Weis Children s Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CONNECTIVE TISSUE GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEAR PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; CELL TYPE; DNA BINDING; GENETIC TRANSFECTION; IMMUNOFLUORESCENCE; NONHUMAN; OSTEOBLAST; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; SRC HOMOLOGY DOMAIN; TRANSACTIVATION; TRANSCRIPTION INITIATION; WESTERN BLOTTING;

ANIMALS; CELL LINE; CONNECTIVE TISSUE GROWTH FACTOR; ENZYME ACTIVATION; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVONOIDS; OSTEOBLASTS; PROMOTER REGIONS, GENETIC; RATS; RATS, SPRAGUE-DAWLEY; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SMAD PROTEINS; SRC-FAMILY KINASES; TRANSFORMING GROWTH FACTOR BETA1;

EID: 77954565778     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22173     Document Type: Article

References (89)

1. Abdollah S, Macias-Silva M, Tsukazaki T, Hayashi H, Attisano L, Wrana JL. 1997. Tbeta RI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling. J Biol Chem 272:27678-27685.
2. Arnott JA, Nuglozeh E, Rico MC, Arango-Hisijara I, Odgren PR, Safadi FF, Popoff SN. 2007. Connective tissue growth factor (CTGF/CCN2) is a downstream mediator for TGF-beta1-induced extracellular matrix production in osteoblasts. J Cell Physiol 210:843-852. (Pubitemid 46185053)
3. Arnott JA, Zhang X, Sanjay A, Owen TA, Smock SL, Rehman S, DeLong WG, Safadi FF, Popoff SN. 2008. Molecular requirements for induction of CTGF expression by TGF-beta1 in primary osteoblasts. Bone 42:871-885.
4. Blanchette F, Rivard N, Rudd P, Grondin F,Attisano L, Dubois CM. 2001. Cross-talk between the p42/p44 MAP kinase and Smad pathways in transforming growth factor beta 1-induced furin gene transactivation. J Biol Chem 276:33986-33994. (Pubitemid 37384625)
5. Blom IE, Goldschmeding R, Leask A. 2002. Gene regulation of connective tissue growth factor: New targets for antifibrotic therapy? Matrix Biol 21:473-482.
6. Bonewald LF. 2002. Transforming growth factor-B. In: Bilezikian JP, Raisz LG, Rodan GA, editors. Principles of bone biology. New York: Academic Press. pp 903-918.
7. Bonewald LF, Dallas SL. 1994. Role of active and latent transforming growth factor beta in bone formation. J Cell Biochem 55:350-357. (Pubitemid 24218811)
8. Boyce BF, Yoneda T, Lowe C, Soriano P, Mundy GR. 1992. Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. J Clin Invest 90:1622-1627.
9. Boyce BF, Chen H, Soriano P, Mundy GR. 1993. Histomorphometric and immunocytochemical studies of src-related osteopetrosis. Bone 14:335-340. (Pubitemid 23175749)
10. Centrella M, Canalis E. 1987. Isolation of EGF-dependent transforming growth factor (TGF beta-like) activity from culture medium conditioned by fetal rat calvariae. J Bone Miner Res 2:29-36.
11. Chacko BM, Qin BY, Tiwari A, Shi G, Lam S, Hayward LJ, De Caestecker M, Lin K. 2004. Structural basis of heteromeric smad protein assembly in TGF-beta signaling. Mol Cell 15:813-823. (Pubitemid 39194910)
12. Chang F, Steelman LS, Lee JT, Shelton JG, Navolanic PM, Blalock WL, Franklin RA, McCubrey JA. 2003. Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: Potential targeting for therapeutic intervention. Leukemia 17:1263-1293.
13. Chen Y, Blom IE, Sa S, Goldschmeding R, Abraham DJ, Leask A. 2002. CTGF expression in mesangial cells: Involvement of SMADs, MAP kinase, and PKC. Kidney Int 62:1149-1159.
14. Derynck R, Zhang YE. 2003. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425:577-584. (Pubitemid 37280136)
15. Dignam JD, Martin PL, Shastry BS, Roeder RG. 1983. Eukaryotic gene transcription with purified components. Methods Enzymol 101:582-598. (Pubitemid 13071071)
16. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, Trzaskos JM. 1998. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem 273:18623-18632.
17. Feng XH, Derynck R. 2005. Specificity and versatility in tgf-beta signaling through Smads. Annu Rev Cell Dev Biol 21:659-693. (Pubitemid 41740650)
18. Foulds CE, Nelson ML, Blaszczak AG, Graves BJ. 2004. Ras/mitogen- activated protein kinase signaling activates Ets-1 and Ets-2 by CBP/p300 recruitment. Mol Cell Biol 24:10954-10964.
19. Furukawa F, Matsuzaki K, Mori S, Tahashi Y, Yoshida K, Sugano Y, Yamagata H, Matsushita M, Seki T, Inagaki Y, Nishizawa M, Fujisawa J, Inoue K. 2003. p38 MAPK mediates fibrogenic signal through Smad3 phosphorylation in rat myofibroblasts. Hepatology 38:879-889.
20. Galliher AJ, Schiemann WP. 2006. Beta3 integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition inmammary epithelial cells. Breast Cancer Res 8:R42.
21. Galliher AJ, Schiemann WP. 2007. Src phosphorylates Tyr284 in TGF-beta type II receptor and regulates TGF-beta stimulation of p38 MAPK during breast cancer cell proliferation and invasion. Cancer Res 67:3752-3758.
22. Galliher-Beckley AJ, Schiemann WP. 2008. Grb2 binding to Tyr284 in TbetaR-II is essential for mammary tumor growth and metastasis stimulated by TGF-beta. Carcinogenesis 29:244-251.
23. Gautschi O, Tepper CG, Purnell PR, Izumiya Y, Evans CP, Green TP, Desprez PY, Lara PN, Gandara DR, Mack PC, Kung HJ. 2008. Regulation of Id1 expression by SRC: Implications for targeting of the bone morphogenetic protein pathway in cancer. Cancer Res 68:2250-2258.
24. Graness A, Cicha I, Goppelt-Struebe M. 2006. Contribution of Src-FAK signaling to the induction of connective tissue growth factor in renal fibroblasts. Kidney Int 69: 1341-1349.
25. Granet C, Vico AG, Alexandre C, Lafage-Proust MH. 2002. MAP and src kinases control the induction of AP-1 members in response to changes in mechanical environment in osteoblastic cells. Cell Signal 14:679-688.
26. Grotendorst GR, Okochi H, Hayashi N. 1996. A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ 7:469-480. (Pubitemid 26362091)
27. Hayashida T, Poncelet AC, Hubchak SC, Schnaper HW. 1999. TGF-beta1 activates MAP kinase in human mesangial cells:Apossible role in collagen expression. Kidney Int 56:1710-1720. (Pubitemid 29518171)
28. Hayashida T, Decaestecker M, Schnaper HW. 2003. Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells. FASEB J 17:1576-1578.
29. Hayashida T, Wu MH, Pierce A, Poncelet AC, Varga J, Schnaper HW. 2007. MAP-kinase activity necessary for TGFbeta1-stimulated mesangial cell type I collagen expression requires adhesion-dependent phosphorylation of FAK tyrosine 397. J Cell Sci 120:4230-4240.
30. Hock JM, Canalis E, Centrella M. 1990. Transforming growth factor-beta stimulates bone matrix apposition and bone cell replication in cultured fetal rat calvariae. Endocrinology 126:421-426. (Pubitemid 20037172)
31. Holmes A, Abraham DJ, Sa S, Shiwen X, Black CM, Leask A. 2001. CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling. J Biol Chem 276:10594-10601. (Pubitemid 38089227)
32. Imamichi Y,Waidmann O, Hein R, Eleftheriou P, Giehl K, Menke A. 2005. TGF beta-induced focal complex formation in epithelial cells is mediated by activated ERK and JNK MAP kinases and is independent of Smad4. Biol Chem 386:225-236. (Pubitemid 40485428)
33. Joo CK, Kim HS, Park JY, Seomun Y, Son MJ, Kim JT. 2008. Ligand release-independent transactivation of epidermal growth factor receptor by transforming growth factor-beta involves multiple signaling pathways. Oncogene 27:614-628. (Pubitemid 351158894)
34. Kaabeche K, Lemonnier J, Le Mee S, Caverzasio J, Marie PJ. 2004. Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation. J Biol Chem 279:36259-36267. (Pubitemid 39128962)
35. Kamaraju AK, Roberts AB. 2005. Role of Rho/ROCK and p38 MAP kinase pathways in transforming growth factor-beta-mediated Smad-dependent growth inhibition of human breast carcinoma cells in vivo. J Biol Chem 280:1024-1036.
36. Kartsogiannis V, Ng KW. 2004. Cell lines and primary cell cultures in the study of bone cell biology. Mol Cell Endocrinol 228:79-102. (Pubitemid 39482521)
37. Katz S, Boland R, Santillan G. 2006. Modulation of ERK 1/2 and p38 MAPK signaling pathways by ATP in osteoblasts: Involvement of mechanical stress-activated calcium influx, PKC and Src activation. Int J Biochem Cell Biol 38:2082-2091. (Pubitemid 44397616)
38. Kim JT, Joo CK. 2002. Involvement of cell-cell interactions in the rapid stimulation of Cas tyrosine phosphorylation and Src kinase activity by transforming growth factor-beta 1. J Biol Chem 277:31938-31948.
39. Kim HP, Lee MS, Yu J, Park JA, Jong HS, Kim TY, Lee JW, Bang YJ. 2004. TGF-beta1 (transforming growth factor-beta1)-mediated adhesion of gastric carcinoma cells involves a decrease in Ras/ERKs (extracellular-signal-regulated kinases) cascade activity dependent on c-Src activity. Biochem J 379:141-150.
40. Kim HP, Kim TY, Lee MS, Jong HS, Lee JW, Bang YJ. 2005. TGF-beta1-mediated activations of c-Src and Rac1 modulate levels of cyclins and p27(Kip1) CDK inhibitor in hepatoma cells replated on fibronectin. Biochim Biophys Acta 1743:151-161.
41. Kretzschmar M, Doody J, Timokhina I, Massague J. 1999. A mechanism of repression of TGFbeta/Smad signaling by oncogenic Ras. Genes Dev 13:804-816. (Pubitemid 29169840)
42. Kutz SM, Higgins CE, Samarakoon R, Higgins SP, Allen RR, Qi L, Higgins PJ. 2006. TGF-beta 1-induced PAI-1 expression is E box/USF-dependent and requires EGFR signaling. Exp Cell Res 312:1093-1105.
43. Leask A, Abraham DJ. 2003. The role of connective tissue growth factor, a multifunctional matricellular protein, in fibroblast biology. Biochem Cell Biol 81:355-363. (Pubitemid 38186975)
44. Leask A, Holmes A, Black CM, Abraham DJ. 2003. Connective tissue growth factor gene regulation. Requirements for its induction by transforming growth factor-beta 2 in fibroblasts. J Biol Chem 278:13008-13015. (Pubitemid 36800068)
45. Leivonen SK, Hakkinen L, Liu D, Kahari VM. 2005. Smad3 and extracellular signal-regulated kinase 1/2 coordinately mediate transforming growth factor-beta-induced expression of connective tissue growth factor in human fibroblasts. J Invest Dermatol 124:1162-1169. (Pubitemid 40847402)
46. Liu P, Zhang C, Feng JB, Zhao YX, Wang XP, Yang JM, Zhang MX, Wang XL, Zhang Y. 2008. Cross talk among Smad, MAPK, and integrin signaling pathways enhances adventitial fibroblast functions activated by transforming growth factor-beta1 and inhibited by Gax. Arterioscler Thromb Vasc Biol 28:725-731.
47. Lowell CA, Niwa M, Soriano P, Varmus HE. 1996. Deficiency of the Hck and Src tyrosine kinases results in extreme levels of extramedullary hematopoiesis. Blood 87:1780-1792. (Pubitemid 26068894)
48. Maeda M, Shintani Y, Wheelock MJ, Johnson KR. 2006. Src activation is not necessary for transforming growth factor (TGF)-beta-mediated epithelial to mesenchymal transitions (EMT) in mammary epithelial cells. PP1 directly inhibits TGF-beta receptors I and II. J Biol Chem 281:59-68. (Pubitemid 43671163)
49. Majeska RJ, Rodan GA. 1982. The effect of 1,25(OH)2D3 on alkaline phosphatase in osteoblastic osteosarcoma cells. J Biol Chem 257:3362-3365. (Pubitemid 12077121)
50. Marzia M, Sims NA, Voit S, Migliaccio S, Taranta A, Bernardini S, Faraggiana T, Yoneda T, Mundy GR, Boyce BF, Baron R, Teti A. 2000. Decreased c-Src expression enhances osteoblast differentiation and bone formation. J Cell Biol 151:311-320.
51. Massague J. 2003. Integration of Smad and MAPK pathways: A link and a linker revisited. Genes Dev 17:2993-2997. (Pubitemid 38040762)
52. Massague J, Chen YG. 2000. Controlling TGF-beta signaling. Genes Dev 14:627-644.
53. Matsuura I, Denissova NG, Wang G, He D, Long J, Liu F. 2004. Cyclin-dependent kinases regulate the antiproliferative function of Smads. Nature 430:226-231. (Pubitemid 38902433)
54. Matsuura I, Wang G, He D, Liu F. 2005. Identification and characterization of ERK MAP kinase phosphorylation sites in Smad3. Biochemistry 44:12546-12553. (Pubitemid 41324345)
55. Mishra R, Zhu L, Eckert RL, Simonson MS. 2007. TGF-beta-regulated collagen type I accumulation: Role of Src-based signals. Am J Physiol Cell Physiol 292:C1361-C1369. (Pubitemid 46631733)
56. Mori Y, Ishida W, Bhattacharyya S, Li Y, Platanias LC, Varga J. 2004. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts. Arthritis Rheum 50:4008-4021.
57. Murillo MM, del Castillo G, Sanchez A, Fernandez M, Fabregat I. 2005. Involvement of EGF receptor and c-Src in the survival signals induced by TGF-beta1 in hepatocytes. Oncogene 24:4580-4587.
58. Nakanishi T, Kimura Y, Tamura T, Ichikawa H, Yamaai Y, Sugimoto T, Takigawa M. 1997. Cloning of a mRNA preferentially expressed in chondrocytes by differential display-PCR from a human chondrocytic cell line that is identical with connective tissue growth factor (CTGF) mRNA. Biochem Biophys Res Commun 234:206-210. (Pubitemid 27267561)
59. Nishida T, Nakanishi T, Asano M, Shimo T, Takigawa M. 2000. Effects of CTGF/Hcs24, a hypertrophic chondrocyte-specific gene product, on the proliferation and differentiation of osteoblastic cells in vitro. J Cell Physiol 184:197-206. (Pubitemid 30432311)
60. Noda M. 1989. Transcriptional regulation of osteocalcin production by transforming growth factor-beta in rat osteoblast-like cells. Endocrinology 124:612-617. (Pubitemid 19057045)
61. Parisi MS, Gazzerro E, Rydziel S, Canalis E. 2005. Expression and regulation of CCN genes in murine osteoblasts. Bone 38:671-677.
62. Pei H, Yordy JS, Leng Q, Zhao Q, Watson DK, Li R. 2003. EAPII interacts with ETS1 and modulates its transcriptional function. Oncogene 22:2699-2709.
63. Rodan GA, Majeska RJ. 1982. Phenotypic maturation of osteoblastic osteosarcoma cells in culture. Prog Clin Biol Res 110:249-259.
64. Safadi FF, Xu J, Smock SL, Kanaan RA, Selim AH, Odgren PR, Marks SC, Jr., Owen TA, Popoff SN. 2003. Expression of connective tissue growth factor in bone: Its role in osteoblast proliferation and differentiation in vitro and bone formation in vivo. J Cell Physiol 196:51-62.
65. Samarakoon R, Higgins PJ. 2008. Integration of non-SMAD and SMADsignaling in TGF-beta1-induced plasminogen activator inhibitor type-1 gene expression in vascular smooth muscle cells. Thromb Haemost 100:976-983.
66. Samarakoon R, Higgins SP, Higgins CE, Higgins PJ. 2008. TGF-beta1-induced plasminogen activator inhibitor-1 expression in vascular smooth muscle cells requires pp60(c-src)/EGFR(Y845) and Rho/ROCK signaling. J Mol Cell Cardiol 44:527-538.
67. Samarakoon R, Higgins CE, Higgins SP, Higgins PJ. 2009. Differential requirement for MEK/ERK and SMAD signaling in PAI-1 and CTGF expression in response to microtubule disruption. Cell Signal 21:986-995.
68. Sato M, Kawai-Kowase K, Sato H, Oyama Y, Kanai H, Ohyama Y, Suga T, Maeno T, Aoki Y, Tamura J, Sakamoto H, Nagai R, Kurabayashi M. 2005. c-Src and hydrogen peroxide mediate transforming growth factor-beta1-induced smooth muscle cell-gene expression in 10T1/2 cells. Arterioscler Thromb Vasc Biol 25:341-347.
69. Shi Y, Massague J. 2003. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113:685-700.
70. Sims N, Baron R. 2000. Bone cells and their function. In: Canalis E, editor. Skeletal growth factors. Philadelphia, PA: Lippincott Williams and Wilkins. pp 1-17.
71. Soriano P, Montgomery C, Geske R, Bradley A. 1991. Targeted disruption of the c-src protooncogene leads to osteopetrosis in mice. Cell 64:693-702. (Pubitemid 121001157)
72. Sowa H, Kaji H, Yamaguchi T, Sugimoto T, Chihara K. 2002a. Activations of ERK1/2 and JNK by transforming growth factor beta negatively regulate Smad3-induced alkaline phosphatase activity and mineralization in mouse osteoblastic cells. J Biol Chem 277:36024-36031.
73. Sowa H, Kaji H, Yamaguchi T, Sugimoto T, Chihara K. 2002b. Smad3 promotes alkaline phosphatase activity and mineralization of osteoblastic MC3T3-E1 cells. J Bone Miner Res 17:1190-1199. (Pubitemid 34680495)
74. Takai H, Araki S, Mezawa M, Kim DS, Li X, Yang L, Li Z, Wang Z, Nakayama Y, Ogata Y. 2008. AP1 binding site is another target of FGF2 regulation of bone sialoprotein gene transcription. Gene 410:97-104.
75. Takigawa M, Nakanishi T, Kubota S, Nishida T. 2003. Role of CTGF/HCS24/ecogenin in skeletal growth control. J Cell Physiol 194:256-266. (Pubitemid 36176888)
76. Tanaka Y, Kobayashi H, Suzuki M, KanayamaN, Terao T. 2004. Transforming growth factor-beta1-dependent urokinase up-regulation and promotion of invasion are involved in Src-MAPK-dependent signaling in human ovarian cancer cells. J Biol Chem 279:8567-8576.
77. Tang CH, Yang RS, Chen YF, Fu WM. 2007. Basic fibroblast growth factor stimulates fibronectin expression through phospholipase C gamma, protein kinase Calpha, c-Src, NF-kappaB, and p300 pathway in osteoblasts. J Cell Physiol 211:45-55.
78. Tsuruda A, Suzuki S, Maekawa T, Oka S. 2004. Constitutively active Src facilitates NGF-induced phosphorylation of TrkA and causes enhancement of the MAPK signaling in SK-N-MC cells. FEBS Lett 560:215-220. (Pubitemid 38264320)
79. Utsugi M, Dobashi K, Ishizuka T, Masubuchi K, Shimizu Y, Nakazawa T, Mori M. 2003. C-Jun-NH2-terminal kinase mediates expression of connective tissue growth factor induced by transforming growth factor-beta1 in human lung fibroblasts. Am J Respir Cell Mol Biol 28:754-761.
80. Varon C, Tatin F, Moreau V, Van Obberghen-Schilling E, Fernandez-Sauze S, Reuzeau E, Kramer I, Genot E. 2006. Transforming growth factor beta induces rosettes of podosomes in primary aortic endothelial cells. Mol Cell Biol 26:3582-3594.
81. Wang G, Matsuura I, He D, Liu F. 2009a. TGF-beta-inducible phosphorylation of Smad3. J Biol Chem 284:9663-9673.
82. Wang SE, Xiang B, Zent R, Quaranta V, Pozzi A, Arteaga CL. 2009b. Transforming growth factor beta induces clustering of HER2 and integrins by activating Src-focal adhesion kinase and receptor association to the cytoskeleton. Cancer Res 69:475-482.
83. Watanabe H, de Caestecker MP, Yamada Y. 2001. Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5cells. J Biol Chem 276:14466-14473. (Pubitemid 37391840)
84. Wrana JL, Maeno M, Hawrylyshyn B, Yao KL, Domenicucci C, Sodek J. 1988. Differential effects of transforming growth factor-beta on the synthesis of extracellular matrix proteins by normal fetal rat calvarial bone cell populations. J Cell Biol 106:915-924.
85. Xie S, Sukkar MB, Issa R, Oltmanns U, Nicholson AG, Chung KF. 2005. Regulation of TGF-beta 1-induced connective tissue growth factor expression in airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 288:L68-L76.
86. Xu J, Smock SL, Safadi FF, Rosenzweig AB, Odgren PR, Marks SC, Jr., Owen TA, Popoff SN. 2000. Cloning the full-length cDNA for rat connective tissue growth factor: Implications for skeletal development. J Cell Biochem 77:103-115.
87. Yang C, Patel K, Harding P, Sorokin A, Glass WF II. 2007. Regulation of TGF-beta1/MAPK-mediated PAI-1 gene expression by the actin cytoskeleton in human mesangial cells. Exp Cell Res 313:1240-1250.
88. Zhu X, Kim JL, Newcomb JR, Rose PE, Stover DR, Toledo LM, Zhao H, Morgenstern KA. 1999. Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitors. Structure 7:651-661.
89. Zirngibl RA, Chan JS, Aubin JE. 2008. Estrogen receptor-related receptor alpha (ERRalpha) regulates osteopontin expression through a non-canonical ERRalpha response element in a cell context-dependent manner. J Mol Endocrinol 40:61-73.